Search Results - "Douwes, M"

Prognostic factors in pediatric pulmonary arterial hypertension: A systematic review and meta-analysis by Ploegstra, Mark-Jan, Zijlstra, Willemijn M.H, Douwes, Johannes M, Hillege, Hans L, Berger, Rolf M.F

“…Abstract Background Despite the introduction of targeted therapies in pediatric pulmonary arterial hypertension (PAH), prognosis remains poor. For the…”
Get full text

Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review by Lokhorst, Chantal, van der Werf, Sjoukje, Berger, Rolf M F, Douwes, Johannes M

“…In pulmonary arterial hypertension, it is recommended to base therapeutic decisions on risk stratification. This systematic review aims to report the…”
Get full text

Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review by Lokhorst, Chantal, van der Werf, Sjoukje, Berger, Rolf M F, Douwes, Johannes M

“…Currently, risk stratification is the cornerstone of determining treatment strategy for patients with pulmonary arterial hypertension (PAH). Since the 2015…”
Get full text

The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study by Douwes, Rianne M, Gomes-Neto, António W, Eisenga, Michele F, Van Loon, Elisabet, Schutten, Joëlle C, Gans, Rijk O B, Naesens, Maarten, van den Berg, Else, Sprangers, Ben, Berger, Stefan P, Navis, Gerjan, Blokzijl, Hans, Meijers, Björn, Bakker, Stephan J L, Kuypers, Dirk

“…Chronic use of proton-pump inhibitors (PPIs) is common in kidney transplant recipients (KTRs). However, concerns are emerging about the potential long-term…”
Get full text

Discrepancy between self‐perceived mycophenolic acid‐associated diarrhea and stool water content after kidney transplantation by Douwes, Rianne M., Swarte, J. Casper, Post, Adrian, Annema, Coby, Harmsen, Hermie J. M., Bakker, Stephan J. L.

“…Background Diarrhea is a well‐known side effect of mycophenolic acid (MPA) use in kidney transplant recipients (KTRs). It is unknown whether self‐reported…”
Get full text

Effect of High versus Low Dairy Consumption on the Gut Microbiome: Results of a Randomized, Cross-Over Study by Swarte, J Casper, Eelderink, Coby, Douwes, Rianne M, Said, M Yusof, Hu, Shixian, Post, Adrian, Westerhuis, Ralf, Bakker, Stephan J L, Harmsen, Hermie J M

“…The influence of dairy on the gut microbiome has not been studied extensively. We performed a randomized cross-over study to analyze the effect of high dairy…”
Get full text

The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial Hypertension by Smits, Faye E, Lokhorst, Chantal, Haarman, Marlies G, Ploegstra, Mark-Jan, Berger, Rolf M F, Douwes, Johannes M

“…The pulmonary artery pulsatility index (PAPi, calculated as (SPAP - DPAP)/mRAP) has been suggested as a measure of right ventricular-vascular coupling (RVVC)…”
Get full text

Effect of renal function on homeostasis of asymmetric dimethylarginine (ADMA): studies in donors and recipients of renal transplants by Said, M. Yusof, Douwes, Rianne M., van Londen, Marco, Minović, Isidor, Frenay, Anne-Roos, de Borst, Martin H., van den Berg, Else, Heiner-Fokkema, M. Rebecca, Kayacelebi, Arslan Arinc, Bollenbach, Alexander, van Goor, Harry, Navis, Gerjan, Tsikas, Dimitrios, Bakker, Stephan J. L.

“…Asymmetric dimethylarginine (ADMA) is a methylated form of arginine and an endogenous nitric oxide synthase inhibitor. Renal function decline is associated…”
Get full text

Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria by Douwes, Johannes M., van Loon, Rosa L.E., Hoendermis, Elke S., Vonk-Noordegraaf, Anton, Roofthooft, Marcus T.R., Talsma, Melle D., Hillege, Hans L., Berger, Rolf M.F.

“…Aims To assess the occurrence and prognostic value of acute vasodilator response (AVR) in paediatric vs. adult pulmonary arterial hypertension, and…”
Get full text

Development of a non-expert risk assessment method for hand-arm related tasks (HARM) by Douwes, M., de Kraker, H.

“…To support health and safety practitioners in their obligation of risk assessment the ‘Hand Arm Risk Assessment Method’ (HARM) was developed. This tool can be…”
Get full text

Cardiac Magnetic Resonance Derived Left Ventricular Eccentricity Index and Right Ventricular Mass Measurements Predict Outcome in Children with Pulmonary Arterial Hypertension by Haarman, Meindina G, Coenraad, Iris, Hagdorn, Quint A J, Hillege, Hans L, Willems, Tineke P, Berger, Rolf M F, Douwes, Johannes M

“…Pulmonary arterial hypertension (PAH) is associated with increased right ventricular (RV) afterload, affecting RV remodeling and RV performance, a major…”
Get full text

Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension by Ploegstra, Mark-Jan, MD, Arjaans, Sanne, BSc, Zijlstra, Willemljn M.H., BSc, Douwes, Johannes M., MD, Vissia-Kazemier, Theresia R., RN, MANP, Roofthooft, Marcus T.R., MD, PhD, Hillege, Hans L., MD, PhD, Berger, Rolf M.F., MD, PhD

“…BACKGROUND Clinical worsening (CW), an increasingly used composite end point in adult pulmonary arterial hypertension (PAH), has not yet been evaluated in…”
Get full text

Branched Chain Amino Acids Are Associated with Physical Performance in Patients with End-Stage Liver Disease by Trillos-Almanza, Maria Camila, Wessel, Hanna, Martínez-Aguilar, Magnolia, van den Berg, Eline H, Douwes, Rianne M, Moshage, Han, Connelly, Margery A, Bakker, Stephan J L, de Meijer, Vincent E, Dullaart, Robin P F, Blokzijl, Hans

“…Decreased circulating branched chain amino acids (BCAA) represent a prominent change in amino acid profiles in patients with end-stage liver disease (ESLD)…”
Get full text

Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation by Mavrogiannis, Emmanouil, Hagdorn, Quint A. J., Bazioti, Venetia, Douwes, Johannes M., Van Der Feen, Diederik E., Oberdorf‐Maass, Silke U., Westerterp, Marit, Berger, Rolf M. F.

“…Pulmonary arterial hypertension (PAH) is a fatal disease characterized by increased pulmonary arterial pressure, inflammation, and neointimal remodeling of…”
Get full text

Are neck flexion, neck rotation, and sitting at work risk factors for neck pain? Results of a prospective cohort study by Ariëns, G A M, Bongers, P M, Douwes, M, Miedema, M C, Hoogendoorn, W E, van der Wal, G, Bouter, L M, van Mechelen, W

“…OBJECTIVE To study the relation between neck pain and work related neck flexion, neck rotation, and sitting. METHODS A prospective cohort study was performed…”
Get full text

Ventricular–vascular coupling is predictive of adverse clinical outcome in paediatric pulmonary arterial hypertension by Dufva, Melanie J, Ivy, Dunbar, Campbell, Kristen, Lam, Aimee, Rauff, Adam, Breeman, Karel T N, Douwes, Johannes M, Berger, Rolf M F, Kheyfets, Vitaly Oleg, Hunter, Kendall

“…AimsVentricular–vascular coupling, the ratio between the right ventricle’s contractile state (Ees) and its afterload (Ea), may be a useful metric in the…”
Get full text

Pulmonary arterial hypertension associated with pulmonary arteriovenous malformations and pulmonary veno-occlusive disease: A devastating combination by Zaaijer, Baukje M., Duppen, Nienke, Willemse, Brigitte W.M., Verhagen, Martijn V., Roofthooft, Marcus T.R., Timens, Wim, Berger, Rolf M.F., Douwes, Johannes M.

“…We describe a case of an adolescent male with the rare combination of pulmonary arterial hypertension (PAH) and pulmonary arteriovenous malformations (PAVM's)…”
Get full text

Frequency and Prognostic Significance of Hemoptysis in Pediatric Pulmonary Arterial Hypertension by Roofthooft, Marcus T.R., MD, Douwes, Johannes M., MD, Vrijlandt, Elianne J.L.E., MD, PhD, Berger, Rolf M.F., MD, PhD

“…Data concerning the prevalence, risk factors, and prognostic significance of hemoptysis in pediatric pulmonary arterial hypertension (PAH) are scarce. A Dutch…”
Get full text

Survival Differences in Pediatric Pulmonary Arterial Hypertension by Zijlstra, Willemijn M.H., BSc, Douwes, Johannes M., MD, Rosenzweig, Erika B., MD, Schokker, Sandor, BSc, Krishnan, Usha, MD, Roofthooft, Marcus T.R., MD, PhD, Miller-Reed, Kathleen, RN, Hillege, Hans L., MD, PhD, Ivy, D. Dunbar, MD, Berger, Rolf M.F., MD, PhD

“…Objectives In order to describe survival and treatment strategies in pediatric pulmonary arterial hypertension (PAH) in the current era of PAH-targeted drugs…”
Get full text

Survival Differences in Pediatric Pulmonary Arterial Hypertension: Clues to a Better Understanding of Outcome and Optimal Treatment Strategies by ZIJLSTRA, Willemijn M. H, DOUWES, Johannes M, ROSENZWEIG, Erika B, SCHOKKER, Sandor, KRISHNAN, Usha, ROOFTHOOFT, Marcus T. R, MILLER-REED, Kathleen, HILLEGE, Hans L, IVY, D. Dunbar, BERGER, Rolf M. F

“…In order to describe survival and treatment strategies in pediatric pulmonary arterial hypertension (PAH) in the current era of PAH-targeted drugs and to…”
Get full text